MacroGenics appoints Eric Risser as President and CEO, succeeding Scott Koenig

MACROGENICS INC

Eric Risser, previously COO since 2022, becomes CEO and Class I director effective Aug 13, 2025.
Risser receives $625,000 base salary, up to 60% annual bonus, and option for 550,000 shares.
Founding CEO Scott Koenig steps down after 24 years; remains as director and advisor.
Risser led over $1.6B in non-dilutive capital; background includes Johnson & Johnson corporate development.
Severance terms include cash and COBRA; change-in-control triggers faster vesting and 1.5x multiplier.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.